(1) Zhihua Liu(#)*, Yahui Zhao(#), Pengzhou Kong(#), Yuhao Liu(#), Jing Huang(#), Enwei Xu(#), Wenqing Wei(#), Guangyu Li, Xiaolong Cheng, Liyan Xue, Yi Li, Hongyan Chen, Shuqing Wei, Ruifang Sun, Heyang Cui, Yongsheng Meng, Meilin Liu, Yang Li, Riyue Feng, Xiao Yu, Rui Zhu, Yenan Wu, Lei Li, Bin Yang, Yanchun Ma, Jiawei Wang, Wenjie Zhu, Dongjie Deng, Yanfeng Xi, Fang Wang, Hongyi Li, Shiping Guo, Xiaofei Zhuang, Xiaoyue Wang, Yuchen Jiao*, Yongping Cui*, Qimin Zhan*, Integrated multi-omics profiling yields a clinically relevant molecular classification for esophageal squamous cell carcinoma, Cancer Cell, 2023, 41(1): 181-195.e9 （并列第一作者，IF=38.585）
(2) Cui Y(#), Chen H(#), Xi R(#), Cui H(#), Zhao Y(#), Xu E(#), Yan T, Lu X, Huang F, Kong P, Li Y, Zhu X, Wang J, Zhu W, Wang J, Ma Y, Zhou Y, Guo S, Zhang L, Liu Y, Wang B, Xi Y, Sun R, Yu X, Zhai Y, Wang F, Yang J, Yang B, Cheng C, Liu J, Song B, Li H, Wang Y, Zhang Y, Cheng X, Zhan Q*, Li Y*, Liu Z*. Whole-genome sequencing of 508 patients identifies key molecular features associated with poor prognosis in esophageal squamous cell carcinoma. Cell Res. 2020, doi: 10.1038/s41422-020-0333-6. (IF= 25.617)
(3)Pengzhou Kong(#), Enwei Xu(#), Yanghui Bi(#), Xiaoqin Xu(#), Xue Liu(#), Bin Song, Ling Zhang, Caixia Cheng, Ting Yan, Yu Qian, Jian Yang, Yanchun Ma, Heyang Cui, Yuanfang Zhai, Binbin Zou, Xiangchen Liu, Yikun Cheng, Shiping Guo, Xiaolong Cheng, Yongping Cui(*). Novel ESCC-related gene ZNF750 as potential Prognostic biomarker and inhibits Epithelial-Mesenchymal Transition through directly depressing SNAI1 promoter in ESCC. Theranostics, 2020, 10(4): 1798-1813. doi:10.7150/ thno.38210. (第一作者，IF=11.556)
(4)Kong Pengzhou(#), Yang Xin(#), Zhang Yingying(#), Dong Huiling, Liu Xiangchen, Xu Xiaoqin, Zhang Xinri, Shi Yiwei, Hou Mingxia, Song Bin. Palbociclib Enhances Migration and Invasion of Cancer Cells via Senescence-Associated Secretory Phenotype-Related CCL5 in Non-Small-Cell Lung Cancer. Journal of Oncology. 2022. doi.org/10.1155/2022/2260625. (第一作者，IF=4.501)
(5)Yanghui Bi(#), Shixing Guo(#), Xiaoqin Xu(#), Pengzhou Kong(#), Heyang Cui(#), Ting Yan, Yanchun Ma, Yikun Cheng, Yunqing Cheng, Xue Liu, Ling Zhang, Caixia Cheng, Enwei Xu, Yu Qian, Jian Yang, Bin Song, Hongyi Li, Fang Wang, Xiaoling Hu, Xiangchen Liu, Xia Niu, Yuanfang Zhai, Jing Liu, Yaoping Li, Xiaolong Cheng, Yongping Cui(*). Decreased ZNF750 promotes angiogenesis in a paracrine manner via activating DANCR/miR-4707-3p/FOXC2 axis in esophageal squamous cell carcinoma. Cell Death & Disease, 2020, 11(4):296. doi: 10.1038/s41419-020-2492-2.（并列第一作者，IF=8.469）
(6) Qian Y(#), Liang X(#), Kong P(#), Cheng Y, Cui H, Yan T, Wang J, Zhang L, Liu Y, Guo S, Cheng X, Cui Y. Elevated DHODH expression promotes cell proliferation via stabilizing β-catenin in esophageal squamous cell carcinoma. Cell Death Dis. 2020, 11(10):862. doi: 10.1038/s41419-020-03044-1. （并列第一作者，IF=8.469）
(7)Bi Y(#), Kong P(#), Zhang L(#), Cui H(#), Xu X(#), Chang F(#), Yan T, Li J, Cheng C, Song B, Niu X, Liu X, Liu X, Xu E, Hu X, Qian Y, Wang F, Li H, Ma Y, Yang J, Liu Y, Zhai Y, Wang Y, Zhang Y, Liu H, Liu J, Wang J(*), Cui Y, Cheng X(*). EP300 as an oncogene correlates with poor prognosis in esophageal squamous carcinoma. J Cancer, 2019, 10(22):5413-5426. doi: 10.7150/jca.34261.（并列第一作者，IF=3.182）
(8)Yan T(#), Cui H(#), Zhou Y(#), Yang B(#), Kong P(#), Zhang Y(#), Liu Y, Wang B, Cheng Y, Li J, Guo S, Xu E, Liu H, Cheng C, Zhang L, Chen L, Zhuang X, Qian Y, Yang J, Ma Y, Li H, Wang F, Liu J, Liu X, Su D, Wang Y, Sun R, Guo S, Li Y, Cheng X, Liu Z, Zhan Q(*), Cui Y(*).Multi-region sequencing unveils novel actionable targets and spatial heterogeneity in esophageal squamous cell carcinoma. Nat Commun, 2019, 11;10(1):1670. doi: 10.1038/s41467-019-09255-1. （并列第一作者，IF=12.121）
(9)Hu X(#), Zhai Y(#), Kong P(#), Cui H(#), Yan T, Yang J, Qian Y, Ma Y, Wang F, Li H, Cheng C, Zhang L, Jia Z, Li Y, Yang B, Xu E, Wang J, Yang J, Bi Y, Chang L, Wang Y,Zhang Y, Song B, Li G, Shi R, Liu J, Zhang M, Cheng X, Cui Y(*). FAT1 prevents epithelial mesenchymal transition (EMT) via MAPK/ERK signaling pathway in esophageal squamous cell cancer. Cancer Letters, 2017, 397:83-93. doi: 10.1016/ j.canlet.2017.03.033. (并列第一作者, IF=6.375)
(10)Wang QS(#), Kong PZ(#), Li XQ, Yang F, Feng YM(*). FOXF2 deficiency promotes epithelial-mesenchymal transition and metastasis of basal-like breast cancer. Breast Cancer Research. 2015, 17(30): doi:10.1186/s13058-015-0531.（并列第一作者，IF=5.88.）
(11)Ling Zhang(#), Yong Zhou(#), Caixia Cheng(#), Heyang Cui(#), Le Cheng(#), Pengzhou Kong(#), Jiaqian Wang(#), Yin Li(#), Wenliang Chen, Bin Song, Fang Wang, Zhiwu Jia, Lin Li, Yaoping Li, Bin Yang, Jing Liu, Ruyi Shi, Yanghui Bi, Yanyan Zhang, Juan Wang, Zhenxiang Zhao, Xiaoling Hu, Jie Yang, Hongyi Li, Zhibo Gao, Gang Chen, Xuanlin Huang, Xukui Yang, Shengqing Wan, Chao Chen, Bin Li, Yongkai Tan, Longyun Chen, Minghui He, Sha Xie, Xiangchun Li, Xuehan Zhuang, Mengyao Wang, Zhi Xia, Longhai Luo, Jie Ma, Bing Dong, Jiuzhou Zhao, Yongmei Song, Yunwei Ou, Enming Li, Liyan Xu, Jinfen Wang, Yanfeng Xi, Guodong Li, Enwei Xu, Jianfang Liang, Xiaofeng Yang, Jiansheng Guo, Xing Chen, Yanbo Zhang, Qingshan Li, Lixin Liu, Yingrui Li, Xiuqing Zhang, Huanming Yang, Dongxin Lin, Xiaolong Cheng, Yongjun Guo, Jun Wang, Qimin Zhan(*), and Yongping Cui(*). Genomic analyses reveal mutational signatures and frequently altered genes in esophageal squamous cell carcinoma. Am J Hum Genet.2015, 2;96(4):597-611.（并列第一作者，IF=10. 987）
(12)Kong PZ(#), Yang F, Li L, Li XQ, Feng YM(*). Decreased FOXF2 mRNA expression indicates early-onset metastasis and poor prognosis for breast cancer patients with histological grade II tumor. PLoS One, 2013, ;8(4):e61591. doi: 10.1371/journal.pone.0061591.（第一作者，IF=4.0）
(13)Hu X, Zhai Y, Shi R, Qian Y, Cui H, Yang J, Bi Y, Yan T, Yang J, Ma Y, Zhang L, Liu Y, Li G, Zhang M, Cui Y, Kong P(*), Cheng X(*). FAT1 inhibits cell migration and invasion by affecting cellular mechanical properties in esophageal squamous cell carcinoma. Oncol Rep, 2018, 39(5):2136-2146. doi: 10.3892/ or.2018.6328.（并列通訊作者，IF=2.976）
(14)Yang B(#), Yan T(#), Cui H(#), Xu E(#), Ma Y(#), Cheng C(#), Zhang L, Kong P, Wang F, Qian Y, Yang J, Li Y, Li H, Bi Y, Hu X, Wang J, Song B, Yang J, Gao W, Liu J, Zou B, Shi R, Zhang Y, Liu H, Liu Y, Zhai Y, Chang L, Wang Y, Zhang Y, Jia Z, Chen X, Xi Y, Li G, Liang J, Guo J, Guo S, Zhang R, Cheng X, Cui Y(*). The macro-evolutionary events in esophageal squamous cell carcinoma. Oncotarget, 2017, 8(68):112770-112782. doi: 10.18632/oncotarget.22625.
(15)Zhang Y(#), Dong J(#), Shi R(#), Feng L, Li Y, Cheng C, Zhang L, Song B, Bi Y, Huang H, Kong P, Guo J(*), Liu J(*). Mps1 is associated with the BRAF(V600E) mutation and predicts poor outcome in patients with colorectal cancer. Oncol Lett, 2019, 17(3):2809-2817. doi: 10.3892/ol.2019.9924.
(16)Yanchun M(#), Yi W(#), Lu W, Yu Q, Jian Y, Pengzhou K, Ting Y, Hongyi L, Fang W, Xiaolong C, Yongping C(*). Triptolide prevents proliferation and migration of Esophageal Squamous Cell Cancer via MAPK/ERK signaling pathway. Eur J Pharmacol, 2019, 15;851:43-51. doi: 10.1016/j.ejphar.
(17)Li Y(#), Zhang Y(#), Xiao S, Kong P, Cheng C, Shi R, Wang F, Zhang L, Wang J, Jia Z, Wu S, Liu Y, Guo J, Cheng X, Cui Y(*), Liu J(*). Mps1 is associated with the BRAF(V600E) mutation but does not rely on the classic RAS/RAF/MEK/ERK signaling pathway in thyroid carcinoma. Oncol Lett, 2018, 15(6):9978-9986. doi: 10.3892/ol.2018.8561.
(18)Yang J(#), Kong P, Yang J, Jia Z, Hu X, Wang Z, Cui H, Bi Y, Qian Y, Li H, Wang F, Yang B, Yan T, Ma Y, Zhang L, Cheng C, Song B, Li Y, Xu E, Liu H, Gao W, Wang J, Liu Y, Zhai Y, Chang L, Wang Y, Zhang Y, Shi R, Liu J, Wang Q, Cheng X, Cui Y(*). High TSTA3 Expression as a Candidate Biomarker for Poor Prognosis of Patients With ESCC. Technol Cancer Res Treat, 2018, 17:1533033818781405. doi: 10.1177/1533033818781405
(19)Cheng C(#), Zhou Y(#), Li H(#), Xiong T(#), Li S(#), Bi Y(#), Kong P, Wang F, Cui H, Li Y, Fang X, Yan T, Li Y, Wang J, Yang B, Zhang L, Jia Z, Song B, Hu X, Yang J, Qiu H, Zhang G, Liu J, Xu E, Shi R, Zhang Y, Liu H, He C, Zhao Z, Qian Y, Rong R, Han Z, Zhang Y, Luo W, Wang J, Peng S, Yang X, Li X, Li L, Fang H, Liu X, Ma L, Chen Y, Guo S, Chen X, Xi Y, Li G, Liang J, Yang X, Guo J, Jia J, Li Q, Cheng X, Zhan Q(*), Cui Y(*). Whole-Genome Sequencing Reveals Diverse Models of Structural Variations in Esophageal Squamous Cell Carcinoma. Am J Hum Genet. 2016, 98(2):256-74. doi:10.1016/j.ajhg.2015.12.013.
(20)Cheng C(#), Cui H(#), Zhang L(#), Jia Z(#), Song B(#), Wang F(#), Li Y, Liu J, Kong P, Shi R, Bi Y, Yang B, Wang J, Zhao Z, Zhang Y, Hu X, Yang J, He C, Zhao Z, Wang J, Xi Y, Xu E, Li G, Guo S, Chen Y, Yang X, Chen X, Liang J, Guo J, Cheng X, Wang C, Zhan Q(*), Cui Y(*). Genomic analyses reveal FAM84B and the NOTCH pathway are associated with the progression of esophageal squamous cell carcinoma. Gigascience, 2016, 5:1. doi: 10.1186/s13742-015-0107-0.
(21)Cai J(#), Tian AX, Wang QS, Kong PZ, Du X, Li XQ, Feng YM(*). FOXF2 suppresses the FOXC2-mediated epithelial-mesenchymal transition and multidrug resistance of basal-like breast cancer. Cancer Lett, 2015,28;367(2):129-37.
(22)Tian HP(#), Lun SM, Huang HJ, He R, Kong PZ, Wang QS, Li XQ, Feng YM(*). DNA Methylation Affects the SP1-regulated Transcription of FOXF2 in Breast Cancer Cells. J Biol Chem, 2015, 31;290(31):19173-83.
(23)Li XQ(#), Du X, Li DM, Kong PZ, Sun Y, Liu PF, Wang QS, Feng YM(*). ITGBL1 Is a Runx2 Transcriptional Target and Promotes Breast Cancer Bone Metastasis by Activating the TGFβ Signaling Pathway. Cancer Res, 2015, 75(16):3302-3313.
(24)Wang H(#*), Ren S, Xu Y, Miao W, Huang X, Qu Z, Li J, Liu X, Kong P. MicroRNA-195 reverses the resistance to temozolomide through targeting cyclin E1 in glioma cells. Anti-cancer Drugs, 2019, 30(1):81-88.
